Dermorphin

Dermorphin is a natural heptapeptide originally isolated from the skin of South American frogs of the genus Phyllomedusa. It is a highly potent and selective agonist of the mu-opioid receptors, exhibiting a much higher analgesic activity—potentially 30 to 40 times stronger—than morphine, while being less likely to produce rapid drug tolerance. Due to its unique chemical structure, which includes a D-amino acid, it is highly resistant to enzymatic degradation, allowing it to maintain biological activity within the central nervous system for extended periods. This makes Dermorphin an exceptional subject for research into opioid receptor signaling and the development of next-generation pain management therapies.

Beyond its analgesic properties, Dermorphin is studied for its effects on the endocrine and gastrointestinal systems. In laboratory settings, it has been observed to influence the release of various hormones, including prolactin and growth hormone, through its interaction with the hypothalamic-pituitary axis. Researchers also use Dermorphin to study the mechanics of physical dependence and the physiological pathways involved in the perception of pain and stress. As a research compound, it provides critical insights into the molecular biology of G-protein coupled receptors. Provided as a high-purity lyophilized powder, Dermorphin is an essential tool for neuroscientists focusing on neuropharmacology and the complexities of the mammalian opioid system.